FTC sues main pharmacy reward supervisors in excess of insulin selling prices The agency brought action from Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating techniques “artificially inflated” the listing cost of daily life-preserving insulin drugs. Insurers will continue on vertically integrating to maintain much more https://daveshotchickennutrition27272.free-blogz.com/77975559/the-healthcare-news-diaries